Literature DB >> 31233613

Amyotrophic lateral sclerosis: Origins traced to impaired balance between neural excitation and inhibition in the neonatal period.

Matthew C Kiernan1,2, Ulf Ziemann3, Andrew Eisen4.   

Abstract

Amyotrophic lateral sclerosis (ALS) is an adult onset disease but with an increasingly recognized preclinical prodrome. A wide spectrum of investigative approaches has identified loss of inhibitory function at the heart of ALS. In developing an explanation for the onset of ALS, it remains a consideration that ALS has its origins in neonatal derangement of the γ-aminobutyric acid (GABA)-ergic system, with delayed conversion from excitatory to mature inhibitory GABA and impaired excitation/inhibition balance. If this is so, the resulting chronic excitotoxicity could marginalize cortical network functioning very early in life, laying the path for neurodegeneration. The possibility that adult-onset neurodegenerative conditions might have their roots in early developmental derangements is worthy of consideration, particularly in relation to current models of disease pathogenesis. Unraveling the very early molecular events will be crucial in developing a better understanding of ALS and other adult neurodegenerative disorders. Muscle Nerve, 2019.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  GABA; amyotrophic lateral sclerosis; excitation/inhibition balance; neonatal; neurodegeneration

Year:  2019        PMID: 31233613     DOI: 10.1002/mus.26617

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

Review 1.  The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?

Authors:  Rangariroyashe H Chipika; We Fong Siah; Mary Clare McKenna; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2020-10-31       Impact factor: 6.682

2.  ALS is a multistep process in South Korean, Japanese, and Australian patients.

Authors:  Steve Vucic; Mana Higashihara; Gen Sobue; Naoki Atsuta; Yuriko Doi; Satoshi Kuwabara; Seung Hyun Kim; Inah Kim; Ki-Wook Oh; Jinseok Park; Eun Mi Kim; Paul Talman; Parvathi Menon; Matthew C Kiernan
Journal:  Neurology       Date:  2020-02-18       Impact factor: 9.910

Review 3.  Potential Preventive Strategies for Amyotrophic Lateral Sclerosis.

Authors:  B Kuraszkiewicz; H Goszczyńska; T Podsiadły-Marczykowska; M Piotrkiewicz; P Andersen; M Gromicho; J Grosskreutz; M Kuźma-Kozakiewicz; S Petri; B Stubbendorf; K Szacka; H Uysal; M de Carvalho
Journal:  Front Neurosci       Date:  2020-05-26       Impact factor: 4.677

Review 4.  HDAC6 in Diseases of Cognition and of Neurons.

Authors:  Patrizia LoPresti
Journal:  Cells       Date:  2020-12-23       Impact factor: 6.600

Review 5.  Improving clinical trial outcomes in amyotrophic lateral sclerosis.

Authors:  Matthew C Kiernan; Steve Vucic; Kevin Talbot; Christopher J McDermott; Orla Hardiman; Jeremy M Shefner; Ammar Al-Chalabi; William Huynh; Merit Cudkowicz; Paul Talman; Leonard H Van den Berg; Thanuja Dharmadasa; Paul Wicks; Claire Reilly; Martin R Turner
Journal:  Nat Rev Neurol       Date:  2020-12-18       Impact factor: 42.937

Review 6.  Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease.

Authors:  Glen E Kisby; Peter S Spencer
Journal:  Front Neurosci       Date:  2021-12-02       Impact factor: 4.677

Review 7.  Cellular basis of learning and memory in the carotid body.

Authors:  Olivia M S Gold; Emma N Bardsley; Anna P Ponnampalam; Audrys G Pauza; Julian F R Paton
Journal:  Front Synaptic Neurosci       Date:  2022-08-15

8.  MRI-guided histology of TDP-43 knock-in mice implicates parvalbumin interneuron loss, impaired neurogenesis and aberrant neurodevelopment in amyotrophic lateral sclerosis-frontotemporal dementia.

Authors:  Ziqiang Lin; Eugene Kim; Mohi Ahmed; Gang Han; Camilla Simmons; Yushi Redhead; Jack Bartlett; Luis Emiliano Pena Altamira; Isobel Callaghan; Matthew A White; Nisha Singh; Stephen Sawiak; Tara Spires-Jones; Anthony C Vernon; Michael P Coleman; Jeremy Green; Christopher Henstridge; Jeffrey S Davies; Diana Cash; Jemeen Sreedharan
Journal:  Brain Commun       Date:  2021-05-27

9.  Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers-a developmental disorder.

Authors:  Dorothée E Lulé; Hans-Peter Müller; Julia Finsel; Patrick Weydt; Antje Knehr; Ivar Winroth; Peter Andersen; Jochen Weishaupt; Ingo Uttner; Jan Kassubek; Albert C Ludolph
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-08-27       Impact factor: 10.154

10.  Eye movement alterations in presymptomatic C9orf72 expansion gene carriers.

Authors:  Dorothée Lulé; Jan Kassubek; Anna Behler; Antje Knehr; Julia Finsel; Martin S Kunz; Christina Lang; Kathrin Müller; Hans-Peter Müller; Elmar H Pinkhardt; Albert C Ludolph
Journal:  J Neurol       Date:  2021-03-11       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.